文献速递重症综合管理与镇静镇痛儿科与产科急症

苯二氮䓬类药物在PICU谵妄中是否存在安全剂量?PICU Up! pilot试验数据集的二次分析

Is There Any Dose of Benzodiazepines Safe for Delirium in the PICU? A Secondary Analysis of the PICU Up! Pilot Trial Dataset.
PubMed 文献 · Crit Care Explor · 2026-03-31
一句话结论在危重患儿中未发现苯二氮䓬类药物的安全阈值,即使最小剂量也增加次日谵妄风险,应尽可能减少或避免使用。

本研究为PICU Up! pilot试验(多中心随机试验,7个PICU,1006例患者)的二次分析,纳入10644个患者日的前瞻性数据,评估镇静药物与谵妄的关系。多变量logistic回归显示,前一日苯二氮䓬剂量每增加1 mg/kg咪达唑仑等效剂量,谵妄调整比值比(aOR)为1.12(95%CI 1.02-1.25;p=0.020),风险在最低剂量0-0.01 mg/kg时即显著增加(p=0.010)。前一日阿片类药物剂量与谵妄无显著关联(aOR 1.00;95%CI 1.00-1.00;p=0.892)。前一日任何右美托咪定使用(aOR 1.26;95%CI 1.04-1.52;p=0.019)和当日身体约束使用(aOR 1.72;95%CI 1.27-2.31;p<0.001)均与谵妄风险增加相关。作者认为,无论剂量如何,苯二氮䓬类药物的使用应尽可能减少或消除,并对身体约束和右美托咪定采取审慎的个体化策略。

要点

  • 前一日苯二氮䓬剂量每增加1 mg/kg咪达唑仑等效剂量,次日谵妄风险增加(aOR 1.12;95%CI 1.02-1.25;p=0.020)。
  • 谵妄风险增加最明显出现在最低剂量0-0.01 mg/kg(p=0.010),且风险随剂量升高持续增加。
  • 前一日阿片类药物剂量与次日谵妄无显著关联(aOR 1.00;95%CI 1.00-1.00;p=0.892)。
  • 前一日任何右美托咪定使用与次日谵妄风险增加相关(aOR 1.26;95%CI 1.04-1.52;p=0.019)。
  • 当日身体约束使用与谵妄风险增加相关(aOR 1.72;95%CI 1.27-2.31;p<0.001)。

适用人群与场景

  • 危重患儿,来自7个PICU的多中心随机试验PICU Up! pilot数据集,共1006例患者、10644个患者日。

研究设计与关键结果

  • 研究类型为多中心随机试验PICU Up! pilot数据集的二次分析,纳入7个PICU、1006例患者、10644个患者日。
  • 前一日苯二氮䓬剂量每增加1 mg/kg咪达唑仑等效剂量,次日谵妄调整比值比(aOR)为1.12(95%CI 1.02-1.25;p=0.020)。
  • 谵妄风险增加最明显出现在最低剂量0-0.01 mg/kg(p=0.010),风险随剂量升高持续增加。
  • 前一日阿片类药物剂量与次日谵妄无显著关联(aOR 1.00;95%CI 1.00-1.00;p=0.892)。
  • 前一日任何右美托咪定使用与次日谵妄风险增加相关(aOR 1.26;95%CI 1.04-1.52;p=0.019)。
  • 当日身体约束使用与谵妄风险增加相关(aOR 1.72;95%CI 1.27-2.31;p<0.001)。

证据类型、等级与局限

  • 证据类型:多中心随机试验PICU Up! pilot数据集的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,无论剂量如何,苯二氮䓬类药物的使用应尽可能减少或消除。
  • 作者认为,身体约束和右美托咪定使用也与谵妄风险增加相关,因此对每位患者采取个体化方法并强调审慎使用至关重要。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: A better understanding of the relationship between sedative dose and PICU delirium is crucial for delirium prevention.

OBJECTIVES: To identify risk factors for delirium in critically ill children and characterize the dose-response relationship between benzodiazepine administration and next-day delirium in the PICU.

DESIGN, SETTING, AND PARTICIPANTS: A secondary analysis of 10,644 patient-days from prospectively collected data, including sedative and analgesic use and delirium screening from the multicenter, randomized PICU Up! pilot trial, including seven PICUs and 1,006 patients.

MAIN OUTCOMES AND MEASURES: Delirium odds were evaluated using a multivariable logistic regression model adjusted for known delirium risk factors.

RESULTS: Benzodiazepines, opioids, and dexmedetomidine were commonly used in the PICU. A higher previous-day benzodiazepine dose was associated with increased odds of delirium on a given day with an adjusted odds ratio (aOR) of 1.12 per midazolam milligram equivalent per kilogram (95% CI, 1.02-1.25; p = 0.020). The most pronounced increase in delirium risk occurred at the lowest doses, between 0 and 0.01 mg/kg (p = 0.010), with risk continuing to rise at higher doses. Previous-day opioid dose was not associated with changes in the odds of delirium (aOR, 1.00; 95% CI, 1.00-1.00; p = 0.892). Any previous-day dexmedetomidine administration was associated with increased odds of next-day delirium (aOR, 1.26; 95% CI, 1.04-1.52; p = 0.019). Additionally, same-day physical restraint use was associated with increased odds of delirium (aOR, 1.72; 95% CI, 1.27-2.31; p < 0.001).

CONCLUSIONS AND RELEVANCE: No safe benzodiazepine threshold was identified in critically ill children, with delirium risk increased even at minimal doses. The greatest increase in odds occurred at the lowest doses. Hence, regardless of dose, benzodiazepine use should be minimized or eliminated whenever possible. Physical restraints and dexmedetomidine use were also associated with increased risk of delirium; thus, a tailored approach for each patient with an emphasis on judicious use is critical.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Blackman I, De Armas R, Padilla S, et al. Is There Any Dose of Benzodiazepines Safe for Delirium in the PICU? A Secondary Analysis of the PICU Up! Pilot Trial Dataset. Crit Care Explor. 2026. PMID: 41915588. doi:10.1097/CCE.0000000000001389

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。